These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bone and glucocorticoids. Briot K Ann Endocrinol (Paris); 2018 Jun; 79(3):115-118. PubMed ID: 29685453 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments. Lane NE Curr Osteoporos Rep; 2019 Feb; 17(1):1-7. PubMed ID: 30685820 [TBL] [Abstract][Full Text] [Related]
8. [Therapy of glucocorticoid induced osteoporosis]. Arazzi M; Di Fulvio G; Di Pietro LO; Grabocka X; Longo MO; Micioni G; Pezzutto A; Piscitani L; Schiazza A; Silvestri S; Vigilante G; Amoroso L; Bonomini M G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207221 [TBL] [Abstract][Full Text] [Related]
9. Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis? Teitelbaum SL; Seton MP; Saag KG Arthritis Rheum; 2011 Feb; 63(2):325-8. PubMed ID: 21279986 [No Abstract] [Full Text] [Related]
10. Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs. Iwamoto N; Okamoto M; Tsuji S; Endo Y; Takatani A; Shimizu T; Umeda M; Fukui S; Sumiyoshi R; Igawa T; Koga T; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Eguchi K; Ueki Y; Kawakami A J Bone Miner Metab; 2019 May; 37(3):554-562. PubMed ID: 30187273 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced osteoporosis. Silverman SL; Lane NE Curr Osteoporos Rep; 2009 Mar; 7(1):23-6. PubMed ID: 19239826 [TBL] [Abstract][Full Text] [Related]
18. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health. Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG J Am Acad Dermatol; 2017 Jan; 76(1):1-9. PubMed ID: 27986132 [TBL] [Abstract][Full Text] [Related]